Cibus to Participate in the Sidoti Micro Cap Conference

Rhea-AI Summary

Cibus (Nasdaq: CBUS), a leading agricultural biotechnology company specializing in proprietary gene editing technologies for seed trait development, has announced its participation in the upcoming Sidoti Micro Cap Conference. The company's presentation will be delivered by Co-Founders Rory Riggs (CEO and Chairman) and Peter Beetham (President and COO) on Thursday, January 23, 2025, at 1:45 p.m. ET (10:45 a.m. PT). The presentation will be accessible via webcast to registered participants.

News Market Reaction – CBUS

+1.15%

1 alert

+1.15% News Effect

On the day this news was published, CBUS gained 1.15%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer, will host a presentation at the Sidoti Micro Cap Conference.

Presentation details
Date: Thursday, January 23, 2025
Time: 1:45 p.m. ET (10:45 a.m. PT)        
Webcast link: https://sidoti.zoom.us/webinar/register/WN_zgpeW_rJSbS6UDdU4sskZQ

About Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus’ focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a pipeline of five productivity traits including important traits for Pod Shatter Reduction, Sclerotinia (disease) resistance, and weed management. Its initial traits for Pod Shatter Reduction and weed management are in commercial development with leading seed companies such as Nuseed Americas Inc. in Canola as well as Nutrien Ltd. and Interoc S.A. in Rice in the United States and Latin America. Its other pipeline traits including Sclerotinia resistance are in advanced greenhouse and field trials stages.

CIBUS CONTACTS:

INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636

Jeff Sonnek – ICR
jeff.sonnek@icrinc.com

MEDIA RELATIONS
Colin Sanford
colin@bioscribe.com
203-918-4347

FAQ

When is Cibus (CBUS) presenting at the Sidoti Micro Cap Conference 2025?

Cibus (CBUS) is presenting at the Sidoti Micro Cap Conference on Thursday, January 23, 2025, at 1:45 p.m. ET (10:45 a.m. PT).

Who will be presenting for Cibus (CBUS) at the Sidoti Conference?

Rory Riggs (Co-Founder, CEO, and Chairman) and Peter Beetham (Co-Founder, President, and COO) will be hosting the presentation for Cibus at the Sidoti Conference.

How can investors access Cibus's (CBUS) Sidoti Conference presentation?

Investors can access the presentation through a webcast by registering at the provided Zoom link: https://sidoti.zoom.us/webinar/register/WN_zgpeW_rJSbS6UDdU4sskZQ

What is the main business focus of Cibus (CBUS)?

Cibus is a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits in seeds.